Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Acquired Immunodeficiency Syndrome × Emtricitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

Ritonavir 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 dolutegravir 1 Papillomavirus Vaccines 1 Nucleosides 1 Nevirapine 1 Lopinavir 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 Emtricitabine 1 Darunavir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡